Innovative AI Robots Take Shape in South Korea
A South Korean startup utilizes data from real workers to shape AI robots that can mimic human skill
Sidra Medicine, an institution under the Qatar Foundation, has been distinguished as a ZEISS labs@location Reference Customer thanks to its Advanced Imaging Core (AIC). This marks a significant milestone in the realm of advanced medical imaging and biomedical research.
This accolade positions Sidra Medicine among a prestigious group of leading global research hospitals, renowned academic medical institutions, and top-tier scientific facilities recognized for their advancements in microscopy and imaging technologies.
The ZEISS labs@location Program fosters collaboration between ZEISS and top-tier laboratories worldwide. This initiative emphasizes the development of cutting-edge imaging applications, scientific training, expert demonstrations, and knowledge sharing in the imaging science domain.
According to Abbirami Sathappan, who leads the Advanced Imaging Core at Sidra Medicine, this recognition underscores the center's expertise, robust infrastructure, and collaborative research environment. The designation is expected to further enhance the institution's capacity to support researchers and clinicians through advanced imaging workflows that expedite scientific discoveries and relevant clinical research.
The recognition came after a thorough assessment of Sidra Medicine's Advanced Imaging Core, which underscored the center's superior imaging capabilities, operational excellence, scientific proficiency, and commitment to providing high-level training and knowledge transfer.
The facility was commended for facilitating complex imaging tasks, publication-quality scientific research, and collaborative biomedical initiatives.
Prof. Khalid Fakhro, Chief Research Officer at Sidra Medicine, expressed pride in receiving this prestigious acknowledgment. He highlighted that Sidra Medicine is committed to investing in state-of-the-art research platforms and innovative testing capabilities that directly enhance patient care and medical advancements.
He further noted that this ZEISS recognition bolsters Sidra Medicine’s mission to improve diagnostics and increase understanding of rare and complex health conditions, ultimately leading to more precise treatments and improved patient outcomes.